Ocular Adverse Events following Use of Immune Checkpoint Inhibitors for Metastatic Malignancies期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

按检索

Ocular Adverse Events following Use of Immune Checkpoint Inhibitors for Metastatic Malignancies

Authors:	Carl W Noble Sapna S Gangaputra Ian A Thompson Amy Yuan Andrea B Apolo Jung-Min Lee

Institution:	1. Department of Ophthalmology, George Washington University , Washington DC, USA https://orcid.org/0000-0002-3399-4238;2. Department of Ophthalmology, Vanderbilt Eye Institute , Nashville, USA https://orcid.org/0000-0001-5461-8568;3. Department of Ophthalmology, National Eye Institute , Bethesda, USA;4. Department of Ophthalmology, Massachusetts Eye and Ear Institute , Boston, USA https://orcid.org/0000-0003-2568-2434;5. Department of Oncology, National Cancer Institute , Bethesda, USA https://orcid.org/0000-0001-9409-1836;6. Department of Oncology, National Cancer Institute , Bethesda, USA

Abstract:	ABSTRACT Purpose To report the clinical features, severity, and management of ocular immune-related adverse events (irAEs) in the setting of immune checkpoint inhibitor therapy for metastatic malignancies.

Keywords:	Adverse checkpoint events inflammation inhibitor

Purpose